Canopy Growth Corporation (CGC)

Over the past six months, Canopy Growth's stock price has declined, with a share price of $0.89 as of March 27, 2026, representing a 1.82% decrease from March 31, 2025. The stock decreased by 20.23% in the past month and 9.35% over the last 12 months. Recent earnings reports have shown the company missing analyst estimates, with Q3 2026 EPS reported at ($0.10). Significant events include the completion of the acquisition of MTL Cannabis and an executive transition at Storz & Bickel. Analyst ratings have varied from "Buy" to "Hold" or "Sell".

Information regarding the demand seasonality for Canopy Growth Corp.'s products and services is not extensively detailed in the provided search results. However, the launch of holiday-inspired cannabis products and seasonal offerings from its Tweed brand in December 2024 suggests that certain periods, such as the holiday season, may see targeted product releases to align with consumer demand.

Canopy Growth Corporation is a Canadian cannabis company involved in the production, distribution, and sale of cannabis and cannabinoid-based products for recreational and medical use. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry, and also in Agricultural Commodities/Milling. Its product portfolio includes dried cannabis flowers, oils, concentrates, softgel capsules, edibles, beverages, and vapes, along with vaporization devices through its Storz & Bickel segment. Key brands include Tweed, 7ACRES, DOJA, and Spectrum Therapeutics.

Canopy Growth's primary operations are in Canada, Europe (specifically Germany), and Australia, serving medical cannabis patients globally. In Canada, it operates in both the medical and adult-use markets. The company also has indirect exposure to the U.S. THC market through its non-controlling interest in Canopy USA, LLC, which has ownership in companies like Acreage Holdings and Wana Wellness.

In the past year, Canopy Growth has focused on product innovation and market positioning, including launching holiday-inspired cannabis products under the Tweed brand in December 2024 and introducing "Deelish," a new cannabis brand targeting the value segment, in March 2026. The company's Apollo Cannabis Clinics were also named "Best Medical Cannabis Clinic" in March 2026. These events suggest efforts to maintain and enhance brand perception through product offerings and recognition.

Canopy Growth Corporation's ownership is a mix of institutional, retail, and individual investors. Institutional investors hold approximately 2.61% to 5.95% of the stock, while retail investors hold around 93.43%. Insiders own about 0.61% to 3.67% of the stock. Major institutional owners include Jane Street Group, Llc, Toroso Investments, LLC, and Susquehanna International Group, Llp. Greenstar II Holdings LLC is the largest individual shareholder, owning 104.50 million shares, representing 27.66% of the company.